Colonization, Asymptomatic
11
3
3
5
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
0.0%
0 terminated out of 11 trials
100.0%
+13.5% vs benchmark
27%
3 trials in Phase 3/4
0%
0 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (11)
Carbapenem-resistant Pseudomonas Aeruginosa: the SAMPAN Study.
Encapsulated Probiotics & Gut Microbiota
Safety and Efficacy of Lyophilized Fecal Microbiota Transplantation Via Capsules for Intestinal Multidrug-resistant Bacteria Decolonization
Nasal Antisepsis for C. Auris Prevention
Decolonization Efficacy of Polyhexanide vs. Mupirocin
Studying Respiratory Infections and Colonisation in Children Using Daily Minimally-invasive Nasal Sampling
Impact of Reducing Colistin Use on Colistin Resistance in Humans and Poultry in Indonesia
Incidence of Colonization by Multidrug-resistant Organisms in Mechanically Ventilated Patients With Severe COVID-19
Decolonization of Carbapenem-resistant Enterobacterales (CRE) in Patients With Faecal Carriage of CRE With Neomycin
A Clinical Simulation Study of a Test Material on the Anterior Nares
Immunity and Nasal Fungal Colonization